Sara Rogers is a clinician scientist at Texas A&M University, where she leads precision medicine initiatives focused on improving medication safety and patient outcomes. She holds joint appointments in the Department of Translational Medical Sciences and the School of Engineering Medicine and serves as a Fellow of the Texas A&M Healthcare Access Institute.
Dr. Rogers is the co-founder and President of the American Society of Pharmacovigilance, a nonprofit dedicated to advancing medication safety through research, education, and policy. Her work centers on reducing adverse drug events (ADEs), which remain a leading cause of preventable harm, by strengthening pharmacovigilance systems and integrating emerging tools into clinical care. She also serves as Chair of the Personalized Medicine Expert Committee and as a member of the Council of Experts at the United States Pharmacopeia, where she contributes to the development of standards supporting the safe and effective implementation of precision medicine.
Dr. Rogers’ research focuses on patient access to pharmacogenomic testing, ethical considerations in precision medicine, and the development of clinical decision support tools to guide medication management in complex patients. She has led national efforts to advance policy solutions for medication safety, including convening stakeholders across the healthcare ecosystem to modernize adverse event reporting and prevention strategies.
Shedding Light on the Risks
& Benefits of Medications
